NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

Not Yet RecruitingN/A

Sponsor: Mayo Clinic

Conditions: COVID-19

Interventions: C11 ER176 Tracer

Countries: United States

The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Mayo Clinic patients with a previously confirmed infection with the novel SARS-CoV-2 virus who have been seen in the Post COVID Clinic through GIM Integrative Medicine \& Health Section or approval by MAGPIES research group.
* Be able to participate fully in all aspects of the study.
* Have understood and signed study informed consent.

Exclusion Criteria:

* Lacking the capacity to consent.
* Prisoners and institutionalized individuals.
* Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the LLLT treatment phase and are unwilling to use a reliable form of contraception.

  o Acceptable forms include:
  * Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants
  * Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam, cream, or gel that kills sperm)
  * Intrauterine device (IUD)
  * Total hysterectomy or tubal ligation
  * Abstinence (no sex).
* Those patients that have implants that would prevent them from having a PET Scan.
* Patients that have claustrophobia.
* Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

Locations (1)

Rochester, Minnesota, United States